Femasys Inc (FEMY) stock
FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.15+0.03 (+2.68%)
Close on Nov 18, 2026Market cap $9.63MP/E –Yield –
Femasys shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Femasys's shares outstanding was 3M at Jun 30, 2026. For fiscal 2025 it was 2M, up 77.6% from the year before. The highest annual figure on record is 2M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2M | +77.6% |
| FY2024 | Dec 31, 2024 | 1M | +44.7% |
| FY2023 | Dec 31, 2023 | 1M | +30.2% |
| FY2022 | Dec 31, 2022 | 1M | +76.0% |
| FY2021 | Dec 31, 2021 | 0M | +599.3% |
| FY2020 | Dec 31, 2020 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 3M | +132.5% |
| Q1 FY2026 | Mar 31, 2026 | 4M | +210.5% |
| Q4 FY2025 | Dec 31, 2025 | 3M | +175.7% |
| Q3 FY2025 | Sep 30, 2025 | 2M | +84.5% |
| Q2 FY2025 | Jun 30, 2025 | 1M | +30.0% |
| Q1 FY2025 | Mar 31, 2025 | 1M | +15.5% |
| Q4 FY2024 | Dec 31, 2024 | 1M | +6.6% |
| Q3 FY2024 | Sep 30, 2024 | 1M | +47.3% |
| Q2 FY2024 | Jun 30, 2024 | 1M | +69.5% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +83.4% |
| Q4 FY2023 | Dec 31, 2023 | 1M | +81.2% |
| Q3 FY2023 | Sep 30, 2023 | 1M | +27.8% |
| Q2 FY2023 | Jun 30, 2023 | 1M | +11.0% |
| Q1 FY2023 | Mar 31, 2023 | 1M | +0.6% |
| Q4 FY2022 | Dec 31, 2022 | 1M | -0.2% |
| Q3 FY2022 | Sep 30, 2022 | 1M | +0.1% |
| Q2 FY2022 | Jun 30, 2022 | 1M | +468.9% |
| Q1 FY2022 | Mar 31, 2022 | 1M | +1086.1% |
| Q4 FY2021 | Dec 31, 2021 | 1M | +1118.4% |
| Q3 FY2021 | Sep 30, 2021 | 1M | +1134.7% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +117.4% |
| Q1 FY2021 | Mar 31, 2021 | 0M | – |
| Q4 FY2020 | Dec 31, 2020 | 0M | – |
| Q3 FY2020 | Sep 30, 2020 | 0M | – |
| Q2 FY2020 | Jun 30, 2020 | 0M | – |
See a number that looks wrong?